News | December 18, 2006

Datascope to Distribute Sorin Stents

In a new, five-year agreement signed last week, Datascope’s InterVascular Division will become the distributor of Sorin Group’s peripheral vascular stent products worldwide, excluding the U.S. and Japan. Datascope will have an option to acquire that side of the Sorin business.

Sorin's family of peripheral stent products are dedicated to the treatment of peripheral arterial disease ("PAD") and use the Carbofilm Technology, comprising clinically proven biocompatible and hemocompatible characteristics. The product line includes balloon-expandable and self-expanding stent systems principally for use in the treatment of the iliac arteries, renal arteries and infrapopliteal lesions, as well as balloon systems for use in PTA (Percutaneous Transluminal Angioplasty).

Outside of the U.S. and Japan the global market for peripheral vascular stents and PTA balloons is estimated at $192 million annually, and growing due to an increase in diagnostic procedures as well as the aging population and higher incidences of diabetes, high blood pressure, obesity and hypercholesterolemia -- all major risk factors for PAD.

For more information visit www.datascope.com.


Related Content

Feature | Stents Peripheral | Dave Fornell, Editor

November 6, 2019 – The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) ...

Home November 06, 2019
Home
Technology | Stents Peripheral

October 5, 2018 — Veryan Medical Ltd has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent System ...

Home October 05, 2018
Home
News | Stents Peripheral

April 27, 2018 — Intact Vascular Inc. recently closed a Series C financing totaling $20 million. This financing is ...

Home April 27, 2018
Home
News | Stents Peripheral

July 26, 2017 — Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the Knee ...

Home July 26, 2017
Home
News | Stents Peripheral

July 14, 2017 — Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational ...

Home July 14, 2017
Home
News | Stents Peripheral

April 28, 2017 — Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world setting ...

Home April 28, 2017
Home
News | Stents Peripheral

March 16, 2017 — W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris Vascular ...

Home March 16, 2017
Home
News | Stents Peripheral

March 2, 2017 — Intact Vascular Inc. announced in February that its Tack Optimized Balloon Angioplasty II Below the Knee ...

Home March 02, 2017
Home
News | Stents Peripheral

December 13, 2016 — Biotronik announced the presentation of data confirming the efficacy of the Pulsar-18 bare metal ...

Home December 13, 2016
Home
News | Stents Peripheral

December 8, 2016 — LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow ...

Home December 08, 2016
Home
Subscribe Now